Share
When you hear the words Alzheimer's disease, what do you think of? The truth is, the picture most of us have of the disease is incomplete. Alzheimer's disease doesn't start when someone starts to lose their memory. It actually starts years – sometimes decades – earlier. The Rethinking Alzheimer's Disease Podcast is an engaging, narrative-style podcast miniseries for those curious or motivated to learn about Alzheimer’s disease. Perhaps you have a family member with Alzheimer’s disease, or ca ...
…
continue reading
Manage episode 520073449 series 3438380
Content provided by Dr. Dominic D'Agostino PhD, Dr. Angela Poff PhD, and Victoria Field, Dr. Dominic D'Agostino PhD, Dr. Angela Poff PhD, and Victoria Field. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Dominic D'Agostino PhD, Dr. Angela Poff PhD, and Victoria Field, Dr. Dominic D'Agostino PhD, Dr. Angela Poff PhD, and Victoria Field or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
What if the key to treating neurodegenerative diseases lies not in attacking symptoms, but in healing mitochondria? Dr. Matthew Phillips, a neurologist who coined the term "metabolic neurologist," shares groundbreaking insights from his decade-long journey implementing ketogenic diets and fasting protocols for Parkinson's, Alzheimer's, and glioblastoma patients.
In this episode, Dr. Phillips reveals his clinical framework combining metabolic therapies with standard of care, his current glioblastoma trial utilizing 5-day fasting cycles with chemotherapy, and why he believes mitochondrial dysfunction is the root cause of neurodegeneration.
Questions Answered in This Episode:
- What initially drew you to understanding brain metabolism and how did your journey begin?
- How do you implement metabolic therapies in practice and determine patient candidacy?
- What is the most clinically relevant mechanism of metabolic therapy?
- Does your trial evidence suggest metabolic interventions are adjunctive or disease-modifying treatments?
- Why aren't metabolic therapies more widely adopted for conditions where conventional options are limited?
- What power do patients have to prevent or address early cognitive decline through their own actions?
Dr. Phillips challenges the medical dogma that has kept metabolic therapies on the sidelines, advocating for a merger of "germ theory" and "terrain theory" approaches that could revolutionize how we treat the most devastating neurological conditions.
Sign-up to our Live Q&A Exploring Metabolic Neurology with Dr. Phillips here.
Learn more about Dr. Phillips on his website.
Special thanks to the sponsors of this episode:
✅Genova Connect – Get 15% off any test kit with code METABOLICLINK here.
✅ iRestore - Get a huge discount on the iRestore Illumina Face Mask when you use the code METABOLICLINK here.
✅Piquelife.com - Get the Pu'er Bundle for 20% off here.
In every episode of The Metabolic Link, we'll uncover the very latest research on metabolic health and therapy. If you like this episode, please share it, subscribe, follow, and leave us a comment or review on whichever platform you use to tune in!
You can find us on all your major podcast players here and full episodes are also up on our Metabolic Health Summit YouTube channel!
Find us on social:
Please keep in mind: The Metabolic Link does not provide medical or health advice, but rather general information that does not serve as a substitute for a licensed healthcare professional. Never delay in seeking medical advice from an appropriately licensed medical provider for any health condition that you may have.
81 episodes
))
